medRxiv PreprintsInternational20 November 2026
Methamphetamine use reshapes cellular and plasma immune signatures in a lineage-specific manner in people with HIV
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Methamphetamine use is common among people with HIV (PWH) and is associated with worse neurocognitive and clinical outcomes, but how it reshapes HIV-associated immune dysregulation across cell types and compartments is unknown. In this cross-sectional and observational study, we performed single-cell RNA sequencing of peripheral blood mononuclear cells (PBMCs) from controls without HIV, PWH without methamphetamine use and PWH who use methamphetamine, then scored pathway enrichment, cytokine response and transcription factor activity in each cell population. We then profiled plasma from the sam
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.